Enhertu first secured approval in 2019 for patients with high levels of HER2, a protein that promotes cancer cell growth. In ...

Research that has not yet been peer-reviewed shows the newest blood test is more than 80% accurate in detecting colon cancer ...

As part of the second Trump Administration's diversity witchhunt, cancer research and other crucial projects have been paused ...

Robert F. Kennedy Jr. may soon be America's top pharmaceutical regulator. That is cause for concern in Seattle’s biotech ...

Already banned in cosmetics and topical medicines since 1990, the Food and Drug Administration announced on Wednesday that ...

The FDA has banned red dye No. 3 in food and ingested drugs, the agency announced. But what exactly is red dye No. 3, and why ...

Astra is due to pay Daiichi US$175 million in milestones after the US approval, the companies said. Enhertu is cleared in the ...

Zentalis Pharmaceuticals said it would cut 40% of its workforce as part of a restructuring to support the late-stage development of its cancer-drug azenosertib.

Over 35 years after the first study linking the artificial food dye Red 3 to thyroid cancer in rats was published, the U.S.

Studies going back decades have shown a potential link between artificial food dyes and attention deficit hyperactivity ...

On January 15, 2025, the Food and Drug Administration (FDA) amended its color additive regulations by revoking its ...

Enhertu is a HER2-directed antibody and topoisomerase inhibitor conjugate. Approval of the new indication was based on data from the phase 3 DESTINY-Breast06 trial (ClinicalTrials.gov Identifier: ...